Orthofix Medical Inc (OFIX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Orthofix Medical Inc stock (OFIX) is currently trading at $11.72. Orthofix Medical Inc PS ratio (Price-to-Sales) is 0.57. Analyst consensus price target for OFIX is $17.25. WallStSmart rates OFIX as Sell.
- OFIX PE ratio analysis and historical PE chart
- OFIX PS ratio (Price-to-Sales) history and trend
- OFIX intrinsic value — DCF, Graham Number, EPV models
- OFIX stock price prediction 2025 2026 2027 2028 2029 2030
- OFIX fair value vs current price
- OFIX insider transactions and insider buying
- Is OFIX undervalued or overvalued?
- Orthofix Medical Inc financial analysis — revenue, earnings, cash flow
- OFIX Piotroski F-Score and Altman Z-Score
- OFIX analyst price target and Smart Rating
Orthofix Medical Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Orthofix Medical Inc (OFIX) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around peg ratio and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Orthofix Medical Inc (OFIX) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
90.03% of shares held by major funds and institutions
Trading at 1.04x book value, attractively priced
Supporting Valuation Data
Orthofix Medical Inc (OFIX) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Very expensive relative to growth, significant premium
Revenue growing slowly at 2.00% annually
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Orthofix Medical Inc (OFIX) Detailed Analysis Report
Overall Assessment
This company scores 38/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 3 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 1.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Institutional Own., Price/Book. Valuation metrics including Price/Sales (0.57), Price/Book (1.04) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including PEG Ratio (3.79) suggest expensive pricing. Growth concerns include Revenue Growth at 2.00%, which may limit upside. Profitability pressure is visible in Return on Equity at -19.30%, Operating Margin at -1.27%, Profit Margin at -11.20%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -19.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 2.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
OFIX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
OFIX's Price-to-Sales ratio of 0.57x sits near its historical average of 0.6x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 12% below its historical high of 0.65x set in Mar 2026, and 0% above its historical low of 0.57x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.7x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Orthofix Medical Inc (OFIX) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Orthofix Medical Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 822M with 2% growth year-over-year. The company is currently unprofitable, posting a -11.2% profit margin.
Key Findings
Generating 18M in free cash flow and 28M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -11.2% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Debt management: total debt of 204M is significantly higher than cash (66M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Orthofix Medical Inc.
Bottom Line
Orthofix Medical Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Orthofix Medical Inc(OFIX)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is headquartered in Lewisville, Texas.